A Record Year: A Look at the Biotech IPOs for Q4 2018

The Nasdaq indicated that there was a record amount of biotech initial public offerings (IPOs) this year, including some individual record-breakers—Moderna Therapeutics, Allogene Therapeutics and Rubius Therapeutics. The total for the year is around $8.2 billion raised, breaking 2014’s record of $6.5 billion.